Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SIFI Block for Analgesia in Total Hip Arthroplasty
NCT02933671Phase 4Terminated
- Sponsor
- Duke University
- Start
- Aug 2017
- Primary completion
- Mar 2020
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
Phase 4, randomised, double-blind trial of ropivacaine in postoperative pain (2 arms), sponsored by Duke University. Primary endpoint: Numeric Pain Score at 4 Hours Postoperatively. Started Aug 2017; status: terminated.
02
Drugs
ropivacaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT02933671.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02933671.